FIRMQUARRYResearch workspace

GOVERNMENT CONTRACT / PURCHASE ORDER

ADVANCED CELL DIAGNOSTICS INC:1187802 [22-005223]

Awarded to ADVANCED CELL DIAGNOSTICS, INC.

PIID 75N90022P00165US · USAspendingBiotechnology & Pharmaceuticals
$10.6K
Data last updated Oct 22, 2026 · Source: USAspending
Transaction obligation$10,601sum disclosed on award record
Current contract valueNot reportednot interchangeable with obligation
Potential contract valueNot reportedincluding options if reported
Award dateFeb 28, 2022
Company legal name
ADVANCED CELL DIAGNOSTICS, INC.
UEI / CAGE
UD6XW8DAGLK6 / Not reported
Parent award
Not reported
Awarding agency
Department of Health and Human Services
Subagency
National Institutes of Health
Industry
Biotechnology & Pharmaceuticals
NAICS
325412
PSC
6640
Performance period
Not reported — Not reported
Recipient address
7707 GATEWAY BLVD STE 200, NEWARK, ALAMEDA, CA, 94560
Place of performance
NEWARK, ALAMEDA, CA, 94560
Source last modified
Nov 3, 2026

Description

ADVANCED CELL DIAGNOSTICS INC:1187802 [22-005223]

View federal source ↗

Derived from official transactions

Contract lifecycle

  1. Award announced

    ADVANCED CELL DIAGNOSTICS INC:1187802 [22-005223]

    US · usaspendingSource ↗
  2. Value increased

    ADVANCED CELL DIAGNOSTICS INC:1187802 [22-005223]

    US · usaspending$10.6KSource ↗

Point-in-time model

Contract change outlook

Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

Uncollapsed source history

Transactions and modifications

Action dateModificationAction typeExact obligationCurrent totalPotential totalDescriptionSource
Feb 28, 20220Not reported$10,600.80Not reportedNot reportedADVANCED CELL DIAGNOSTICS INC:1187802 [22-005223]USAspending ↗